Surgical treatment of myelomeningocele: Year 2000 hospitalization, outcome, and cost analysis in the US

Child's Nervous System

Volumn 23, Issue 10, 2007, Pages 1125-1127

  Sin, Anthony H ^a   Rashidi, Mahmoud ^a   Caldito, Gloria ^b   Nanda, Anil ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Myelomeningocele; Nationwide inpatient database

Indexed keywords

BRAIN VENTRICLE PERITONEUM SHUNT; CHILD HOSPITALIZATION; COST BENEFIT ANALYSIS; FEMALE; HOSPITALIZATION COST; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TEACHING HOSPITAL; TREATMENT OUTCOME;

COSTS AND COST ANALYSIS; DATABASES, FACTUAL; ETHNIC GROUPS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; MENINGOMYELOCELE; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULOPERITONEAL SHUNT;

EID: 34548630219     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-007-0375-9     Document Type: Review

References (26)

1. Bea Munoz M, Diaz Llopis I, Martinez Agullo E, Lopez A, Garcia Aymerich V, Forner Valero JV (1994) A multicentre study of the hospital care of 1500 patients with myelomeningocele. Paraplegia 32(8):561-564
2. Blaymore Bier JA, Liebling JA, Morales Y, Carlucci M (1996) Parents' and pediatricians' views of individuals with meningomyelocele. Clin Pediatr (Phila) 35(3):113-117
3. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA (2001) Spina bifida outcome: A 25-year prospective. Pediatr Neurosurg 34(3):114-120
4. Brau RH, Rodriguez R, Ramirez MV, Gonzalez R, Martinez V (1990) Experience in the management of myelomeningocele in Puerto Rico. J Neurosurg 72(5):726-731
5. Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, Hernanz-Schulman M, Lowe LH, Reed GW (1999) Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 282(19):1819-1825
6. Eckstein HB, Macnab GH (1966) Myelomeningocele and hydrocephalus. The impact of modern treatment. Lancet 1(7442):842-845
7. Enger PO, Svendsen F, Wester K (2003) CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 145(4):243-248 (discussion 248)
8. Feldman JG, Stein SC, Klein RJ, Kohl S, Casey G (1982) The prevalence of neural tube defects among ethnic groups in Brooklyn, New York. J Chronic Dis 35(1):53-60
9. Freeman JM (1973) Chapter 9. To treat or not to treat: Ethical dilemmas of the infant with a myelomeningocele. Clin Neurosurg 20:134-146
10. Gamache FW Jr (1995) Treatment of hydrocephalus in patients with meningomyelocele or encephalocele: A recent series. Childs Nerv Syst 11(8):487-488
11. Gross RH, Cox A, Tatyrek R, Pollay M, Barnes WA (1983) Early management and decision making for the treatment of myelomeningocele. Pediatrics 72(4):450-458
12. Henderson JB (1982) Measuring the benefits of screening for open neural tube defects. J Epidemiol Community Health 36(3):214-219
13. Hendricks KA, Simpson JS, Larsen RD (1999) Neural tube defects along the Texas-Mexico border, 1993-1995. Am J Epidemiol 149(12):1119-1127
14. Jeelani NO, Jaspan T, Punt JA (1999) Lesson of the week: Tethered cord syndrome after myelomeningocoele repair. BMJ 318(7182):516-517
15. Lorber J (1966) Incidence and epidemiology of myelomeningocele. Clin Orthop Relat Res 45:81-83
16. Macias R (1986) Surgical considerations in the management of myelomeningocele. Childs Nerv Syst 2(1):10-12
17. McLaughlin JF, Shurtleff DB, Lamers JY, Stuntz JT, Hayden PW, Kropp RJ (1985) Influence of prognosis on decisions regarding the care of newborns with myelodysplasia. N Engl J Med 312(25):1589-1594
18. McLone DG (1983) Results of treatment of children born with a myelomeningocele. Clin Neurosurg 30:407-412
19. McNeely PD, Howes WJ (2004) Ineffectiveness of dietary folic acid supplementation on the incidence of lipomyelomeningocele: Pathogenetic implications. J Neurosurg Spine 100(2 Suppl Pediatrics):98-100
20. Perry VL, Albright AL, Adelson PD (2002) Operative nuances of myelomeningocele closure. Neurosurgery 51(3): 719-723 (discussion 723-724)
21. Ransohoff J, Mathews ES (1969) Neurosurgical management of patients with spina bifida and myelomeningocele. Med Clin North Am 53(3):493-496
22. Rintoul NE, Sutton LN, Hubbard AM, Cohen B, Melchionni J, Pasquariello PS, Adzick NS (2002) A new look at myelomeningoceles: Functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 109(3):409-413
23. Sarwark JF (1996) Spina bifida. Pediatr Clin North Am 43(5):1151-1158 (Review)
24. Shurtleff DB, Hayden PW, Loeser JD, Kronmal RA (1974) Myelodysplasia: decision for death or disability. N Engl J Med 291(19):1005-1011
25. Stein SC, Feldman JG, Friedlander M, Klein RJ (1982) Is myelomeningocele a disappearing disease? Pediatrics 69(5):511-514
26. Tuli S, Drake J, Lamberti-Pasculli M (2003) Long-term outcome of hydrocephalus management in myelomeningoceles. Childs Nerv Syst 19(5-6):286-291